Drug-induced Hemolysis in G6PD Deficiency: an Unusual Presentation of a Common Clinical Condition

2Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) deficiency can present a diagnostic dilemma owing to the varying degrees of disease severity and the wide range of precipitating factors. Here, we report a case of a 56-year-old man who presented with signs and symptoms of heart failure and, during the course of treatment, developed intravascular hemolysis. On investigation, he was found to be G6PD deficient. Following discontinuation of the fixed-dose combination of isosorbide dinitrate and hydralazine, the clinical condition of the patient improved, and there were no further episodes of hemolysis. The case highlights the need for a high degree of suspicion of G6PD deficiency in patients with unexplained signs and symptoms of intravascular hemolysis.

Cite

CITATION STYLE

APA

Padakanti, A., Ashok Shenoy, K., Kamath, A., & Chakrapani, M. (2019). Drug-induced Hemolysis in G6PD Deficiency: an Unusual Presentation of a Common Clinical Condition. Acta Medica, 62(4), 166–169. https://doi.org/10.14712/18059694.2020.7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free